101 related articles for article (PubMed ID: 20190806)
1. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
Ochiai H; Takenobu H; Nakagawa A; Yamaguchi Y; Kimura M; Ohira M; Okimoto Y; Fujimura Y; Koseki H; Kohno Y; Nakagawara A; Kamijo T
Oncogene; 2010 May; 29(18):2681-90. PubMed ID: 20190806
[TBL] [Abstract][Full Text] [Related]
2. The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
Slack A; Chen Z; Tonelli R; Pule M; Hunt L; Pession A; Shohet JM
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):731-6. PubMed ID: 15644444
[TBL] [Abstract][Full Text] [Related]
3. SESN1 functions as a new tumor suppressor gene via Toll-like receptor signaling pathway in neuroblastoma.
Hua Z; Chen B; Gong B; Lin M; Ma Y; Li Z
CNS Neurosci Ther; 2024 Mar; 30(3):e14664. PubMed ID: 38516781
[TBL] [Abstract][Full Text] [Related]
4. Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.
Stermann A; Huebener N; Seidel D; Fest S; Eschenburg G; Stauder M; Schramm A; Eggert A; Lode HN
Cancer Immunol Immunother; 2015 Oct; 64(10):1215-27. PubMed ID: 26076666
[TBL] [Abstract][Full Text] [Related]
5. MYCN drives oncogenesis by cooperating with the histone methyltransferase G9a and the WDR5 adaptor to orchestrate global gene transcription.
Liu Z; Zhang X; Xu M; Hong JJ; Ciardiello A; Lei H; Shern JF; Thiele CJ
PLoS Biol; 2024 Mar; 22(3):e3002240. PubMed ID: 38547242
[TBL] [Abstract][Full Text] [Related]
6. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex.
Trimarchi JM; Fairchild B; Wen J; Lees JA
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1519-24. PubMed ID: 11171983
[TBL] [Abstract][Full Text] [Related]
7. Optimal combination of MYCN differential gene and cellular senescence gene predicts adverse outcomes in patients with neuroblastoma.
Tan J; Wang C; Jin Y; Xia Y; Gong B; Zhao Q
Front Immunol; 2023; 14():1309138. PubMed ID: 38035110
[TBL] [Abstract][Full Text] [Related]
8. High-throughput molecular and histopathologic profiling of tumor tissue in a novel transplantable model of murine neuroblastoma: new tools for pediatric drug discovery.
Stauffer JK; Orentas RJ; Lincoln E; Khan T; Salcedo R; Hixon JA; Back TC; Wei JS; Patidar R; Song Y; Hurd L; Tsokos M; Lai EW; Eisenhofer G; Weiss W; Khan J; Wigginton JM
Cancer Invest; 2012 Jun; 30(5):343-63. PubMed ID: 22571338
[TBL] [Abstract][Full Text] [Related]
9. Unsaturated Fatty Acid Synthesis Is Associated with Worse Survival and Is Differentially Regulated by
Sheeter DA; Garza S; Park HG; Benhamou LE; Badi NR; Espinosa EC; Kothapalli KSD; Brenna JT; Powers JT
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672672
[No Abstract] [Full Text] [Related]
10. MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma.
Liu T; Gu L; Wu Z; Albadari N; Li W; Zhou M
Front Oncol; 2022; 12():1058726. PubMed ID: 36505784
[TBL] [Abstract][Full Text] [Related]
11. A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma.
Perri P; Ponzoni M; Corrias MV; Ceccherini I; Candiani S; Bachetti T
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771690
[TBL] [Abstract][Full Text] [Related]
12. Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs.
Ciaccio R; De Rosa P; Aloisi S; Viggiano M; Cimadom L; Zadran SK; Perini G; Milazzo G
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884690
[TBL] [Abstract][Full Text] [Related]
13. Mxi1 and mxi1-0 antagonize N-myc function and independently mediate apoptosis in neuroblastoma.
Erichsen DA; Armstrong MB; Wechsler DS
Transl Oncol; 2015 Feb; 8(1):65-74. PubMed ID: 25749179
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions.
Joshi S
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722460
[TBL] [Abstract][Full Text] [Related]
15. Functional and physical communication between oncoproteins and tumor suppressors.
Prochownik EV
Cell Mol Life Sci; 2005 Nov; 62(21):2438-59. PubMed ID: 16143828
[TBL] [Abstract][Full Text] [Related]
16. Olive Oil Components as Novel Antioxidants in Neuroblastoma Treatment: Exploring the Therapeutic Potential of Oleuropein and Hydroxytyrosol.
Gonçalves M; Aiello A; Rodríguez-Pérez M; Accardi G; Burgos-Ramos E; Silva P
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542729
[TBL] [Abstract][Full Text] [Related]
17. CX‑5461 potentiates imatinib‑induced apoptosis in K562 cells by stimulating
Dai C; Cui X; Wang J; Dong B; Gao H; Cheng M; Jiang F
Exp Ther Med; 2024 Mar; 27(3):107. PubMed ID: 38356673
[TBL] [Abstract][Full Text] [Related]
18. An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma.
Singh HP; Shayler DWH; Fernandez GE; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2200721119. PubMed ID: 35867756
[TBL] [Abstract][Full Text] [Related]
19. Molecular Basis and Clinical Features of Neuroblastoma.
Takita J
JMA J; 2021 Oct; 4(4):321-331. PubMed ID: 34796286
[TBL] [Abstract][Full Text] [Related]
20. Neuronal Differentiation-Related Epigenetic Regulator
Jiménez C; Antonelli R; Masanas M; Soriano A; Devis-Jauregui L; Camacho J; Magdaleno A; Guillén G; Hladun R; Jubierre L; Roma J; Llobet-Navas D; Sánchez de Toledo J; Moreno L; Gallego S; Segura MF
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
